Email Alert | RSS

北京大学学报（医学版） ›› 2019, Vol. 51 ›› Issue (4): 673-677. doi: 10.19723/j.issn.1671-167X.2019.04.013

• 论著 • 上一篇    下一篇

MRI对肾细胞癌静脉瘤栓侵犯下腔静脉壁的术前评估

吴静云1,米悦2,刘水1,姚林2,唐琦2,何志嵩2,王霄英1,△()   

  1. 1. 北京大学第一医院医学影像科,北京　100034
    2. 北京大学第一医院泌尿外科,北京　100034
  • 收稿日期:2019-04-16 出版日期:2019-08-18 发布日期:2019-09-03
  • 通讯作者: 王霄英 E-mail:cjr.wangxiaoying@vip.163.com

Evaluating inferior vena cava wall invasion in renal cell carcinoma tumor thrombus with MRI

Jing-yun WU1,Yue MI2,Shui LIU1,Lin YAO2,Qi TANG2,Zhi-song HE2,Xiao-ying WANG1,△()   

  1. 1.Department of Radiology, Peking University First Hospital, Beijing 100034, China
    2.Department of Urology, Peking University First Hospital, Beijing 100034, China
  • Received:2019-04-16 Online:2019-08-18 Published:2019-09-03
  • Contact: Xiao-ying WANG E-mail:cjr.wangxiaoying@vip.163.com

RICH HTML

 9   

PDF (PC)

228

摘要：

目的:评价MRI对肾细胞癌下腔静脉瘤栓侵犯下腔静脉壁的诊断价值。方法:回顾性分析2010—2018年在北京大学第一医院行肾根治性切除术及下腔静脉取栓术的肾细胞癌患者,术前行1.5 T或3.0 T MRI检查的56例患者被纳入本研究。由两位影像科医生测量术前MRI图像瘤栓所在水平肾静脉及下腔静脉最大径、下腔静脉瘤栓的长度,并评判瘤栓是否充满下腔静脉腔达两侧缘、瘤栓边缘是否光滑、瘤栓与下腔静脉壁分界是否清晰、下腔静脉壁正常信号是否改变等征象。基于病理证实下腔静脉壁受累与否将患者分为两组,对临床资料及MRI征象进行单因素分析及多因素回归分析。结果:56例患者中男性43例、女性13例,平均年龄(55.64±0.43)岁,有17例(30.4%)病理证实下腔静脉壁受累, 大部分为透明细胞癌。下腔静脉壁受累组与非受累组比较,下腔静脉瘤栓的长度更长[(7.91±3.59) cm vs. (5.94±3.57) cm,P=0.049]、瘤栓充满下腔静脉腔(P=0.002)、瘤栓边缘不光滑(P=0.005)、瘤栓与下腔静脉壁分界不清晰(P=0.001)、下腔静脉壁正常信号改变(P<0.001)出现的概率更大,结合这五个指标诊断下腔静脉壁受累的敏感性及特异性为94.12%和79.49%。结论:MRI可作为评估下腔静脉瘤栓侵犯静脉壁的方法,结合下腔静脉瘤栓的长度及MRI征象可以获得较高的诊断敏感性及特异性。

关键词: 癌, 肾细胞, 瘤栓, 腔静脉, 下, 磁共振成像

Abstract:

Objective: To evaluate the diagnostic performance of MRI for the assessment of inferior vena cava (IVC) wall invasion by IVC thrombus in patients with renal cell carcinoma (RCC).Methods: We retrospectively collected patients who underwent radical nephrectomy and thrombectomy for RCC between 2010 and 2018 at Peking University First Hospital. All the patients underwent imaging on a 1.5 Tesla or 3.0 Tesla MRI scanner. Fifty-six patients met the inclusion criteria. Preoperative imaging was reviewed by two radiologists blinded to details of the patient’s surgical procedure and histopathology. Two radiologists measured the maximum anterior-posterior diameter and coronal diameters of the IVC and renal vein, and the craniocaudal extent of tumor thrombus, and evaluated the MRI features of IVC thrombus, including occlusion of the IVC lumen,the margin of the tumor thrombus (smooth vs. irregular), contact of the IVC thrombus and IVC wall, and altered signal of the IVC wall. Univariable and multivariable associations of clinical and radiographic features with IVC wall invasion were evaluated by Logistic regression.Results: Of the 56 patients [male: 43, female: 13, mean age: (55.64±0.43) years], 17 (30.36%) were detected with IVC wall invasion, and most were clear cell carcinoma. Tumor thrombus with IVC wall invasion showed an increase in length of IVC thrombus [(7.91±3.59) cm vs. (5.94±3.57) cm, P=0.049], and more features of complete occlusion of the IVC lumen (P=0.002),irregular margin of the IVC thrombs (P=0.005), contact of the IVC thrombus and IVC wall (P=0.001), and altered signal of the low-intensity vessel wall (P<0.001), with a sensitivity of 94.12% and a specificity of 79.49%.Conclusion: The present study indicates that MRI could be a means of evaluating RCC with IVC wall invasion, and the combination of tumor thrombus length and subjective impression of IVC wall invasion achieved a high sensitivity and specificity for diagnosis.

Key words: Carcinoma, renal cell, Thrombus, Vena cava, inferior, Magnetic resonance imaging

中图分类号: 

  • R737.11

表1

比较下腔静脉壁受累组及无受累组的临床资料"

Items Invasion (n=17) No invasion (n=39) Statistics P
Age/years, x?±s 57.410±10.038 54.870±12.612 0.535 0.593
Gender, n (%) 1.759 0.180
Male 15 (88.235) 28 (71.795)
Female 2 (11.765) 11 (28.205)
Pathology type, n (%) 8.758 0.271
Clear cell carcinoma 13 (76.471) 30 (76.923)
Papillary carcinoma 2 (11.765) 6 (15.385)
Chromophobe cell carcinoma 0 2 (5.128)
Clear cell carcinoma mixed with papillary carcinoma 0 1 (2.564)
Clear cell carcinoma mixed with chromophobe cell carcinoma 1 (5.882) 0
Collecting duct carcinoma 1 (5.882) 0
Thrombus level, n (%) 3.893 0.273
Ⅰ 1 (5.882) 6 (15.385)
Ⅱ 13 (76.471) 31 (79.487)
Ⅲ 2 (11.765) 2 (5.128)
Ⅳ 1 (5.882) 0

表2

比较下腔静脉壁累组及无受累组MRI特征"

Items Invasion (n=17) No invasion (n=39) Statistics P OR 95%CI
Contact of the IVC thrombus and IVC wall, n (%) 11.793 0.001 12.000 2.398-60.050
No contact 2 (11.765) 24 (61.538)
Contact 15 (88.235) 15 (38.462)
Occlusion of the IVC lumen, n (%) 9.636 0.002 9.706 1.949-48.335
Filling 15 (88.235) 17 (43.590)
No filling 2 (11.765) 22 (56.410)
Margin of the thrombus, n (%) 7.806 0.005 5.804 1.585-21.245
Smooth 4 (23.529) 25 (64.103)
Irregular 13 (76.471) 14 (35.897)
Altered signal of the IVC wall, n (%) 24.521 7.349×10-7 34.286 6.346-185.237
Altered 15 (88.235) 7 (17.949)
No altered 2 (11.765) 32 (82.051)
Length of IVC thrombus/cm 7.906±3.592 5.939±3.570 1.961 0.049
Maximal anterior-posterior diameter of renal vein/cm 1.877±0.549 1.744±0.520 0.957 0.339
Maximal superior-inferior diameter of renal vein/cm 1.953±0.532 1.926±0.559 -0.080 0.936
Maximal anterior-posterior diameter of IVC/cm 3.288±0.704 2.672±1.300 1.837 0.066
Maximal coronal diameter of IVC/cm 3.041±0.780 2.672±1.300 1.641 0.101

图1

结合5个MRI影像学指标二元Logistic回归ROC曲线"

[1] Motzer RJ, Jonasch E, Agarwal N , et al. Kidney cancer, version 2.2017: NCCN Clinical Practice Guidelines in oncology[J]. J Natl Compr Canc Netw, 2017,15(6):804-834.
[2] Ljungberg B, Bensalah K, Canfield S , et al. EAU guidelines on renal cell carcinoma: 2014 update[J]. Eur Urol, 2015,67(5):913-924.
[3] Hatcher PA, Anderson EE, Paulson DF , et al. Surgical management and prognosis of renal cell carcinoma invading the vena cava[J]. J Urol, 1991,145(1):20-23.
[4] Lawindy SM, Kurian T, Kim T , et al. Important surgical consi-derations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus[J]. BJU Int, 2012,110(7):926-939.
[5] Guo HF, Song Y, Na YQ , et al. Value of abdominal ultrasound scan, CT and MRI for diagnosing inferior vena cava tumour thrombus in renal cell carcinoma[J]. Chin Med J (Engl), 2009,122(19):2299-2302.
[6] Neves RJ, Zincke H . Surgical treatment of renal cancer with vena cava extension[J]. Br J Urol, 1987,59(5):390-395.
[7] Ciancio G, Livingstone AS, Soloway M . Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques[J]. Eur Urol, 2007,51(4):988-994.
[8] Kwon TW, Kim H, Moon KM , et al. Surgical treatment of inferior vena cava tumor thrombus in patients with renal cell carcinoma[J]. J Korean Med Sci, 2010,25(1):104-109.
[9] Hatakeyama S, Yoneyama T, Hamano I , et al. Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center[J]. BMC Urol, 2013(13):47.
[10] Chen X, Li S, Xu Z , et al. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience[J]. World J Surg Oncol, 2015(13):14.
[11] Whitson JM, Reese AC, Meng MV . Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus[J]. Urol Oncol, 2013,31(2):259-263.
[12] 中华医学会泌尿外科学分化中国肾癌联盟, 中国肾癌伴下腔静脉癌栓诊疗写作组. 肾癌伴静脉癌栓诊治专家共识[J]. 中华泌尿外科杂志, 2018,39(12):881-884.
[13] Psutka SP, Boorjian SA, Thompson RH , et al. Clinical and radiographic predictors of the need for inferior vena cava resection du-ring nephrectomy for patients with renal cell carcinoma and caval tumour thrombus[J]. BJU Int, 2015,116(3):388-396.
[14] Hallscheidt PJ, Fink C, Haferkamp A , et al. Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation[J]. J Comput Assist Tomogr, 2005,29(1):64-68.
[15] Gupta NP, Ansari MS, Khaitan A , et al. Impact of imaging and thrombus level in management of renal cell carcinoma extending to veins[J]. Urol Int, 2004,72(2):129-134.
[16] Cuevas C, Raske M, Bush WH , et al. Imaging primary and se-condary tumor thrombus of the inferior vena cava: multi-detector computed tomography and magnetic resonance imaging[J]. Curr Probl Diagn Radiol, 2006,35(3):90-101.
[17] Lawrentschuk N, Gani J, Riordan R , et al. Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review[J]. BJU Int, 2005,96(3):291-295.
[18] Adams LC, Ralla B, Bender YY , et al. Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI[J]. Cancer imaging, 2018,18(1):17.
[19] Aslam Sohaib SA, Teh J , et al. Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging[J]. J Urol, 2002,167(3):1271-1275.
[20] Oto A, Herts BR, Remer EM , et al. Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment[J]. AJR Am J Roentgenol, 1998,171(6):1619-1624.
[21] Laissy JP, Menegazzo D, Debray MP , et al. Renal carcinoma: diagnosis of venous invasion with Gd-enhanced MR venography[J]. Eur Radiol, 2000,10(7):1138-1143.
[22] Alayed A, Krishna Sk, Breau RH , et al. Diagnostic accuracy of MRI for detecting inferior vena cava wall invasion in renal cell carcinoma tumor thrombus using quantitative and subjective analysis[J]. AJR Am J Roentgenol, 2019,212(3):562-569.
[23] Myneni L, Hricak H, Carroll PR . Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances[J]. Br J Urol, 1991,68(6):571-578.
[1] 陈震,谷宝鑫,汤玉芳,闫子玉,倪方端,崔念晖. 应用Delphi法构建下颌阻生第三磨牙拔除难度评分量表[J]. 北京大学学报（医学版）, 2022, 54(1): 100-104.
[2] 俞光岩,柳登高,李巍,洪霞,张严妍,朱文瑄,张可夫,李潇,栗占国,刘燕鹰,陈艳,高岩,苏家增. 3类新型慢性唾液腺炎的诊断和治疗[J]. 北京大学学报（医学版）, 2022, 54(1): 13-17.
[3] 周传香,周正,张晔,刘晓筱,高岩. 28例口腔基底样鳞状细胞癌的临床病理分析[J]. 北京大学学报（医学版）, 2022, 54(1): 62-67.
[4] 苏俊琪,宋扬,谢尚. 口腔鳞状细胞癌患者修复重建术后感染的病原学特征及感染风险预测模型的构建[J]. 北京大学学报（医学版）, 2022, 54(1): 68-76.
[5] 陈超伦,苏家增,俞光岩. 酸刺激对腮腺和下颌下腺唾液流率及成分的影响[J]. 北京大学学报（医学版）, 2022, 54(1): 89-94.
[6] 穆东亮,薛铖,安彬,王东信. 硬膜外阻滞与结直肠癌患者术后远期生存状态的关系:一项倾向性评分匹配的回顾性研究[J]. 北京大学学报（医学版）, 2021, 53(6): 1152-1158.
[7] 庄金满,李天润,李选,栾景源,王昌明,冯琦琛,韩金涛. Rotarex经皮机械性血栓切除装置在急性下肢缺血中的应用[J]. 北京大学学报（医学版）, 2021, 53(6): 1159-1162.
[8] 周伟,安金刚,荣起国,张益. 下颌骨颏部骨折联合双侧髁突囊内骨折致伤机制的三维有限元分析[J]. 北京大学学报（医学版）, 2021, 53(5): 983-989.
[9] 田雨,程晓悦,贺慧颖,王国良,马潞林. 肾细胞癌合并尿路瘤栓的临床病理特征: 6例报道及文献回顾[J]. 北京大学学报（医学版）, 2021, 53(5): 928-932.
[10] 吴一凡,张晓圆,任爽,玉应香,常翠青. 基于磁共振的青年男性股四头肌的测量和评估[J]. 北京大学学报（医学版）, 2021, 53(5): 843-849.
[11] 庞泳,张沙,杨华,周柔丽. LAPTM4B-35蛋白作为肝癌血清学诊断新标志物的探讨[J]. 北京大学学报（医学版）, 2021, 53(4): 710-715.
[12] 肖若陶,刘承,徐楚潇,何为,马潞林. 术前血小板参数与局部进展期肾细胞癌预后[J]. 北京大学学报（医学版）, 2021, 53(4): 647-652.
[13] 白杲琛,宋毅,金杰,虞巍,何志嵩. 多西他赛联合卡铂治疗转移性去势抵抗性前列腺癌的临床疗效[J]. 北京大学学报（医学版）, 2021, 53(4): 686-691.
[14] 于妍斐,何世明,吴宇财,熊盛炜,沈棋,李妍妍,杨风,何群,李学松. 延胡索酸水合酶缺陷型肾细胞癌的临床病理特征及预后[J]. 北京大学学报（医学版）, 2021, 53(4): 640-646.
[15] 孙争辉,黄晓娟,董靖晗,刘茁,颜野,刘承,马潞林. 临床T1期肾细胞癌肾窦侵犯的危险因素[J]. 北京大学学报（医学版）, 2021, 53(4): 659-664.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究（英文稿）[J]. 北京大学学报（医学版）, 2009, 41(4): 456 -458 .
[2] 郭岩, 谢铮. 用一代人时间弥合差距——健康社会决定因素理论及其国际经验[J]. 北京大学学报（医学版）, 2009, 41(2): 125 -128 .
[3] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报（医学版）, 2009, 41(2): 135 -140 .
[4] 卢恬, 朱晓辉, 柳世庆, 郑杰, 邱晓彦. 白细胞介素2促进宫颈癌细胞系HeLaS3免疫球蛋白G的表达[J]. 北京大学学报（医学版）, 2009, 41(2): 158 -161 .
[5] 袁惠燕, 张苑, 范田园. 离子交换型栓塞微球及其载平阳霉素的制备与性质研究[J]. 北京大学学报（医学版）, 2009, 41(2): 217 -220 .
[6] 徐莉, 孟焕新, 张立, 陈智滨, 冯向辉, 释栋. 侵袭性牙周炎患者血清中抗牙龈卟啉单胞菌的IgG抗体水平的研究[J]. 北京大学学报（医学版）, 2009, 41(1): 52 -55 .
[7] 祁琨, 邓芙蓉, 郭新彪. 纳米二氧化钛颗粒对人肺成纤维细胞缝隙连接通讯的影响[J]. 北京大学学报（医学版）, 2009, 41(3): 297 -301 .
[8] Jian-wei GU, Emily YOUNG, Zhi-jun PAN, Kevan B. TUCKER, Megan SHPARAGO, Min HUANG, Amelia Purser BAILEY. SD大鼠长期高盐饮食可导致其高血压并改变肾细胞因子基因表达谱[J]. 北京大学学报（医学版）, 2009, 41(5): 505 -515 .
[9] 李宏亮*, 安卫红*, 赵扬玉, 朱曦. 妊娠合并高脂血症性胰腺炎行血液净化治疗1例[J]. 北京大学学报（医学版）, 2009, 41(5): 599 -601 .
[10] 李伟军, 邢晓芳, 曲立科, 孟麟, 寿成超. PRL-3基因C104S位点突变体和CAAX缺失体的构建及表达[J]. 北京大学学报（医学版）, 2009, 41(5): 516 -520 .
ISSN 1671-167X
CN 11-4691/R
主管单位：中华人民共和国教育部
主办单位：北京大学
地址： 北京市海淀区学院路38号 北京大学医学部 《北京大学学报（医学版）》
邮编：100191
电话：010-82801551
Email： xbbjb2@bjmu.edu.cn

《北京大学学报（医学版）》
微信公众号
版权所有 © 2018 《北京大学学报（医学版）》编辑部